Type 2 immunity is maintained during cancer-associated adipose tissue wasting.

Lenehan, Patrick J; Cirella, Assunta; Uchida, Amiko M; Crowley, Stephanie J; Sharova, Tatyana; Boland, Genevieve; Dougan, Michael; Dougan, Stephanie K; Heckler, Max

Lenehan, Patrick J; Cirella, Assunta; Uchida, Amiko M; Crowley, Stephanie J; Sharova, Tatyana; Boland, Genevieve; Dougan, Michael; Dougan, Stephanie K; Heckler, Max.

Afiliação

Lenehan PJ; Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Boston, MA, USA.
Cirella A; Department of Immunology, Harvard Medical School, Boston, MA, USA.
Uchida AM; Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Boston, MA, USA.
Crowley SJ; Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Boston, MA, USA.
Sharova T; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Boland G; Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Boston, MA, USA.
Dougan M; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Dougan SK; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Heckler M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Immunother Adv ; 1(1): ltab011, 2021 Jan.

Article em En | MEDLINE | ID: mdl-34291232

Palavras-chave

adipose tissue; cachexia; pancreatic cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Immunother Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google